טוען...

Comparison of 6-(18)F-Fluoro-L-DOPA, (18)F-2-Deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine tumors with von Hippel-Lindau disease

INTRODUCTION: There is limited data on the utility of 6-(18)F-Fluoro-L-3,4-dihydroxyphenylalanine ((18)F-DOPA) and (18)F-2-Deoxy-D-glucose ((18)F-FDG) in the workup of patients with pancreatic neuroendocrine tumors (PNETs). The aim of our study was to determine the accuracy of (18)F-DOPA and (18)F-F...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
Main Authors:	Kitano, Mio, Millo, Corina, Rahbari, Reza, Herscovitch, Peter, Gesuwan, Krisana, Webb, Richard C., Venkatesan, Aradhana M., Phan, Giao Q., Hughes, Marybeth S., Libutti, Steven K., Nilubol, Naris, Linehan, W. Marston, Kebebew, Electron
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	2011
נושאים:	Article
גישה מקוונת:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3293369/ https://ncbi.nlm.nih.gov/pubmed/22136831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.surg.2011.09.048
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

Comparison of 6-(18)F-Fluoro-L-DOPA, (18)F-2-Deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine tumors with von Hippel-Lindau disease

פריטים דומים